Jump to content
  • RENEW YOUR MEMBERSHIP NOW

    Members who have not renewed by 1st March will have their membership lapsed.

    Renew Now
  • Do you implement GCLP in labs which undertake the analysis of samples from clinical trials?

    This is the course for you
  • Fraud and Misconduct

    This course is designed for the QA professional who will hopefully never encounter clinical fraud, but who wishes to be prepared 'just in case'.

    More Information

Key facts

The number of new RQA members who join the Association each year. We currently have just over 2200 members.

The number of Committee Members in 2018, these volunteers help with everything from new booklets to conference organisation.

The Association is forty years old.

Who are RQA

The Research Quality Association (RQA) is a professional membership body dedicated to informing and advancing its members. We provide status and visibility for individuals engaged in the quality of research concerning pharmaceuticals, agrochemicals, chemicals and medical devices. Since our inception in 1977, the Association has increased and evolved to reflect regulatory changes, the growing impact of regulatory inspection and the ever-changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research.  

Read more+

Our Mission

1. To develop and promote quality standards in scientific research.

2. To facilitate knowledge sharing and transfer through:

  • Discussion
  • Training
  • Seminars
  • Forums 
  • Conferences
  • Publications
  • Podcasts
  • Partnership and co-operation

3. To liaise with regulatory agencies in the development and interpretation of regulations and guidance.

Newsletter

Sign up to the latest news and events.

Latest News

View all news

MHRA Pharmacovigilance Inspection Metrics

The MHRA GPvP inspectorate recently published their latest inspection metrics for the period from April 2017 to March 2018.

Read more+

EMA - Change of Address

The EMA London office will close on the 1st March 2019 and re-open on the 4th March in Amsterdam....

Read more+

EMA Relocation Updates

The European Medicines Agency (EMA) will physically relocate to the Netherlands in early March 2019. The Dutch authorities have already officially handed over the temporary building, the Spark building in Amsterdam Sloterdijk, to EMA’s Executive Director Guido Rasi on 9 January 2019 and EMA is now preparing for its physical move.

Read more+
Stockley Park, Greater London
GlaxoSmithKline
Barnstaple, South West England
Accord Healthcare